Clinical Trials List
2022-09-01 - 2025-06-16
Phase III
Not yet recruiting3
Recruiting2
ICD-10M35.00
Sicca syndrome, unspecified
ICD-10M35.01
Sicca syndrome with keratoconjunctivitis
ICD-10M35.09
Sicca syndrome with other organ involvement
ICD-9710.2
Sicca syndrome
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Tzn-Min Lin Division of Rheumatology
- 林科宏 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Yi-Hsing Chen 無
- HSIN-HUA CHEN 風濕免疫科
- 林靖才 風濕免疫科
- WEN-NAN HUANG 風濕免疫科
- 吳沂達 風濕免疫科
- 謝佳偉 風濕免疫科
- 譚國棟 風濕免疫科
- 廖育婉 風濕免疫科
- 賴國隆 風濕免疫科
- 洪維廷 風濕免疫科
- 陳彥如 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張詩欣 無
- Po-Hao Huang 無
- 黃建中 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
489 participants
